Do the Best Coronary Revascularization Prior TAVR

The presence of coronary artery disease (CAD) in patients with aortic stenosis is high, reaching 50% to70% of cases. This poses a great challenge as to what strategy to use and the things we can do.

Debemos hacer la mejor revasculirazión coronaria previo al TAVIEven though it has been shown complete revascularization is beneficial, it is often difficult to achieve. Instead, reasonable incomplete revascularization should have better evolution (similar to complete revascularization) than incomplete revascularization (ICR) defined as a Residual Syntax Score (rSS) >8 in TAVR. However, there is contradicting information in TAVR.

 

A meta-analysis of 3107 patients included in 6 studies was carried out, with a follow up between 0.7 and 3 years, comparing mortality amongst patients with ICR, reasonable ICR and no CAD disease.


Read also: Elderly Patients with ACS: Clopidogrel or Reduced-Dose Prasugrel?


ICR was associated to higher global mortality, compared against the rest of the groups.  The absence of CAD presented lower mortality compared to ICR (OR 1.85; 95% CI 1.42-2.240; P<0.01), reasonable ICR (OR, 1.69; 95% CI 1.26-2.28; P<0.001) or both groups combined (OR; 1.71; 95% CI, 1.36-2.16; P<0.001).

 

In reasonable ICR patients, there were no differences with those not presenting CAD (OR, 1.11; 95% CI, 0.89-1.39; P=0.33).

 

Conclusion

These outcomes suggest that in patients with coronary artery disease undergoing TAVR, guided rSS revascularization might bring significant benefits as regards mortality. Reasonable revascularization offers a precious opportunity to improve patient prognosis.

 

Commentary

These data suggest we should make an effort to obtain the best revascularization (in one or more procedures) in patients presenting significant CAD that are TAVR candidates.

 

However, note that the present indication poses a great challenge, seeing that it is about a high risk group where most patients are elderly. This involves higher risk in complex PCI, which we should perform taking special care as regards contrast volume, vascular complications and bleeding (the latter notably improved by the use of radial access).

 

Courtesy of Dr. Carlos Fava.

 

Original title: Impact of Coronary Artery Revascularization Completeness on Outcomes of patients With Coronary Artery disease Undergoing Transcatheter Aortic Valve Replacement. A Meta-analysis of Studies Using the residual SYNTAX Score (Synergy Between PCI With Taxus and Cardiac Surgery).

Reference: Guy Witberg, et al . Circ cardiovasc Interv 2018;11:e006000.DOI: 10.1161.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

Embolization of Left Atrial Appendage Closure Devices: Predictors, Prevention, and Management Strategies

Atrial fibrillation is associated with an increased risk of stroke and, in patients with contraindications to anticoagulation, percutaneous left atrial appendage closure represents an...

Coronary revascularization before TAVI: prior PCI or conservative management?

The coexistence of coronary artery disease (CAD) in patients with severe aortic stenosis undergoing TAVI is common, with a reported prevalence ranging from 30%...

Percutaneous Mechanical Aspiration versus Surgical Treatment of Tricuspid Valve Endocarditis

Tricuspid valve infective endocarditis (TVIE) accounts for approximately 5% to 10% of all cases of infective endocarditis. Surgical treatment remains the standard therapy in...

CRT 2026 | TAVI-CLOSE Trial: Dual Suture vs Suture + Plug for Vascular Closure After Transfemoral TAVI

The transfemoral approach is the predominant strategy for transcatheter aortic valve implantation (TAVI). Although vascular complications are currently less frequent, they remain relevant determinants...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

ACVC 2026 | CELEBRATE Trial: Prehospital Zalunfiban Use in STEMI

Optimizing antithrombotic therapy in the prehospital phase of ST-segment elevation myocardial infarction (STEMI) remains challenging due to the delayed onset of action of P2Y12...

ACVC 2026 | BOX Substudy: Mean Arterial Pressure Targets in Cardiogenic Shock After OHCA

Hemodynamic management of cardiogenic shock following ischemic out-of-hospital cardiac arrest (OHCA-AMICS) remains an unresolved issue, particularly regarding optimal mean arterial pressure (MAP) targets and...

ACVC 2026 | FLASH Registry European Cohort: Mechanical Thrombectomy in Pulmonary Embolism

The management of intermediate-high and high-risk pulmonary embolism (PE) remains an area of therapeutic uncertainty, particularly in patients with right ventricular (RV) dysfunction, in...